BARNES & NOBLE EDUCATION INC (BNED) Fundamental Analysis & Valuation

NYSE:BNED • US06777U2006

Current stock price

9.11 USD
-0.06 (-0.65%)
At close:
9.11 USD
0 (0%)
After Hours:

This BNED fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BNED Profitability Analysis

1.1 Basic Checks

  • BNED had negative earnings in the past year.
  • BNED had a positive operating cash flow in the past year.
  • In the past 5 years BNED always reported negative net income.
  • In multiple years BNED reported negative operating cash flow during the last 5 years.
BNED Yearly Net Income VS EBIT VS OCF VS FCFBNED Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • BNED's Return On Assets of -0.89% is in line compared to the rest of the industry. BNED outperforms 43.09% of its industry peers.
  • The Return On Equity of BNED (-3.33%) is comparable to the rest of the industry.
  • BNED has a Return On Invested Capital (2.35%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.89%
ROE -3.33%
ROIC 2.35%
ROA(3y)-8.57%
ROA(5y)-9.14%
ROE(3y)-63.88%
ROE(5y)-53.91%
ROIC(3y)N/A
ROIC(5y)N/A
BNED Yearly ROA, ROE, ROICBNED Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • Looking at the Operating Margin, with a value of 0.95%, BNED is in line with its industry, outperforming 43.90% of the companies in the same industry.
  • The Gross Margin of BNED (20.16%) is worse than 78.05% of its industry peers.
  • In the last couple of years the Gross Margin of BNED has declined.
Industry RankSector Rank
OM 0.95%
PM (TTM) N/A
GM 20.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.9%
GM growth 5Y-2.58%
BNED Yearly Profit, Operating, Gross MarginsBNED Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BNED Health Analysis

2.1 Basic Checks

  • BNED has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for BNED has been increased compared to 1 year ago.
  • The number of shares outstanding for BNED has been reduced compared to 5 years ago.
  • Compared to 1 year ago, BNED has an improved debt to assets ratio.
BNED Yearly Shares OutstandingBNED Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
BNED Yearly Total Debt VS Total AssetsBNED Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • BNED has an Altman-Z score of 1.19. This is a bad value and indicates that BNED is not financially healthy and even has some risk of bankruptcy.
  • BNED's Altman-Z score of 1.19 is on the low side compared to the rest of the industry. BNED is outperformed by 63.41% of its industry peers.
  • A Debt/Equity ratio of 0.43 indicates that BNED is not too dependend on debt financing.
  • The Debt to Equity ratio of BNED (0.43) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z 1.19
ROIC/WACC0.26
WACC9.12%
BNED Yearly LT Debt VS Equity VS FCFBNED Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • BNED has a Current Ratio of 1.41. This is a normal value and indicates that BNED is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.41, BNED is in line with its industry, outperforming 58.54% of the companies in the same industry.
  • BNED has a Quick Ratio of 1.41. This is a bad value and indicates that BNED is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BNED has a better Quick ratio (0.70) than 61.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.7
BNED Yearly Current Assets VS Current LiabilitesBNED Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. BNED Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 99.64% over the past year.
  • BNED shows a small growth in Revenue. In the last year, the Revenue has grown by 7.64%.
  • BNED shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.75% yearly.
EPS 1Y (TTM)99.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.4%
Revenue 1Y (TTM)7.64%
Revenue growth 3Y2.49%
Revenue growth 5Y-2.75%
Sales Q2Q%7.02%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BNED Yearly Revenue VS EstimatesBNED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
BNED Yearly EPS VS EstimatesBNED Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400

More info and screens

Find the best growth stocksShow best growing peers

1

4. BNED Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BNED. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BNED Price Earnings VS Forward Price EarningsBNED Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BNED indicates a somewhat cheap valuation: BNED is cheaper than 63.41% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.65
BNED Per share dataBNED EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BNED Dividend Analysis

5.1 Amount

  • BNED does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BNED Fundamentals: All Metrics, Ratios and Statistics

BARNES & NOBLE EDUCATION INC

NYSE:BNED (3/26/2026, 8:06:58 PM)

After market: 9.11 0 (0%)

9.11

-0.06 (-0.65%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-09
Earnings (Next)N/A
Inst Owners79.9%
Inst Owner Change13.72%
Ins Owners4.92%
Ins Owner Change0.37%
Market Cap312.47M
Revenue(TTM)1.68B
Net Income(TTM)-9.43M
Analysts43.33
Price TargetN/A
Short Float %11.61%
Short Ratio9.99
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF 31.87
P/B 1.1
P/tB 1.47
EV/EBITDA 8.65
EPS(TTM)-0.25
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)0.29
OCFY3.14%
SpS48.9
BVpS8.26
TBVpS6.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.89%
ROE -3.33%
ROCE 2.98%
ROIC 2.35%
ROICexc 2.4%
ROICexgc 2.78%
OM 0.95%
PM (TTM) N/A
GM 20.16%
FCFM N/A
ROA(3y)-8.57%
ROA(5y)-9.14%
ROE(3y)-63.88%
ROE(5y)-53.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.9%
GM growth 5Y-2.58%
F-Score6
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Debt/EBITDA 2.49
Cap/Depr 43.47%
Cap/Sales 0.86%
Interest Coverage 1.17
Cash Conversion 19.94%
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 0.7
Altman-Z 1.19
F-Score6
WACC9.12%
ROIC/WACC0.26
Cap/Depr(3y)42.72%
Cap/Depr(5y)53.47%
Cap/Sales(3y)1.11%
Cap/Sales(5y)1.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.64%
Revenue growth 3Y2.49%
Revenue growth 5Y-2.75%
Sales Q2Q%7.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-124.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.57%
OCF growth 3YN/A
OCF growth 5YN/A

BARNES & NOBLE EDUCATION INC / BNED Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BARNES & NOBLE EDUCATION INC?

ChartMill assigns a fundamental rating of 2 / 10 to BNED.


What is the valuation status of BARNES & NOBLE EDUCATION INC (BNED) stock?

ChartMill assigns a valuation rating of 1 / 10 to BARNES & NOBLE EDUCATION INC (BNED). This can be considered as Overvalued.


What is the profitability of BNED stock?

BARNES & NOBLE EDUCATION INC (BNED) has a profitability rating of 2 / 10.


How financially healthy is BARNES & NOBLE EDUCATION INC?

The financial health rating of BARNES & NOBLE EDUCATION INC (BNED) is 3 / 10.